Related Experiment Video
Updated: Feb 14, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Optogenetics in cancer drug discovery
Michał Kiełbus1, Jakub Czapiński1,2, Adrian Odrzywolski1
1a Department of Biochemistry and Molecular Biology , Medical University of Lublin , Lublin , Poland.
Introduction:
The discovery and domestication of biomolecules that respond to light has taken a light of its own, providing new molecular tools with incredible spatio-temporal resolution to manipulate cellular behavior. Areas covered: The authors herein analyze the current optogenetic tools in light of their current, and potential, uses in cancer drug discovery, biosafety and cancer biology. Expert opinion: The pipeline from drug discovery to the clinic is plagued with drawbacks, where most drugs fail in either efficacy or safety. These issues require the redesign of the pipeline and the development of more controllable/personalized therapies. Light is, aside from inexpensive, almost harmless if used appropriately, can be directed to single cells or organs with controllable penetration, and comes in a variety of wavelengths. Light-responsive systems can activate, inhibit or compensate cell signaling pathways or specific cellular events, allowing the specific control of the genome and epigenome, and modulate cell fate and transformation. These synthetic molecular tools have the potential to revolutionize drug discovery and cancer research.
Insights
Optogenetic tools, which use light to control cellular behavior, offer precise methods for cancer drug discovery and research. These light-responsive biomolecules promise safer, more effective cancer therapies by enabling targeted manipulation of cellular processes.
Area of Science:
- Optogenetics
- Molecular Biology
- Cancer Research
Background:
- Current drug discovery faces challenges with drug efficacy and safety.
- Need for controllable and personalized cancer therapies.
- Light offers a safe, inexpensive, and precisely controllable modality for biological manipulation.
Purpose of the Study:
- Analyze current optogenetic tools.
- Explore their applications in cancer drug discovery, biosafety, and cancer biology.
- Highlight their potential to revolutionize cancer research and therapy.
Main Methods:
- Review and analysis of existing optogenetic tools.
- Discussion of light-responsive biomolecules and their mechanisms.
- Exploration of spatio-temporal control in cellular manipulation.
Main Results:
- Optogenetic tools provide high spatio-temporal resolution for cellular control.
- Light-responsive systems can modulate cell signaling, genome, epigenome, and cell fate.
- Potential to overcome limitations in current drug discovery pipelines.
Conclusions:
- Optogenetics presents a powerful approach for developing safer and more effective cancer drugs.
- These tools can enable personalized therapies by precisely controlling cellular events.
- Significant potential to advance cancer biology and drug discovery.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
Drug toxicity: Drug–Drug Interaction
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Pharmacokinetics: Drug–Drug Interactions
Bioequivalence of Drugs: Drugs with Multiple Indications

